Nanotopography reveals metabolites that maintain the immunomodulatory phenotype of mesenchymal stromal cells
暂无分享,去创建一个
M. Vassalli | P. Reynolds | N. Gadegaard | M. Salmerón-Sánchez | L. Turner | R. Oreffo | A. Saeed | M. Dalby | V. Jayawarna | Karl E. V. Burgess | Hannah Donnelly | M. Tsimbouri | J. Mountford | Yinbo Xiao | J. Wells | J. Bansal | Gavin Blackburn | Mariana A. G. Oliva | Ewan Ross | Jennifer Willis | Anwer Saeed
[1] M. Salmerón-Sánchez,et al. Hurdles to uptake of mesenchymal stem cells and their progenitors in therapeutic products , 2020, The Biochemical journal.
[2] Shouan Zhu,et al. Sodium lactate promotes stemness of human mesenchymal stem cells through KDM6B mediated glycolytic metabolism. , 2020, Biochemical and biophysical research communications.
[3] A. Bartolozzi,et al. Elasticity spectra as a tool to investigate actin cortex mechanics , 2020, Journal of Nanobiotechnology.
[4] M. Grumet,et al. Trends in mesenchymal stem cell clinical trials 2004‐2018: Is efficacy optimal in a narrow dose range? , 2019, Stem cells translational medicine.
[5] Siddhartha Das,et al. Soft substrate maintains proliferative and adipogenic differentiation potential of human mesenchymal stem cells on long-term expansion by delaying senescence , 2019, Biology Open.
[6] S. Nath. Molecular mechanistic insights into uncoupling of ion transport from ATP synthesis. , 2018, Biophysical chemistry.
[7] S. Meng,et al. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning , 2018, Stem Cell Research & Therapy.
[8] Siddhartha Das,et al. Soft Substrate Maintains Proliferative and Adipogenic Differentiation Potential of human Mesenchymal Stem Cells on Long Term Expansion by Delaying Senescence , 2018, bioRxiv.
[9] David S. Wishart,et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..
[10] Matthew J. Dalby,et al. Receptor control in mesenchymal stem cell engineering , 2018 .
[11] C. Strange,et al. Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy , 2017, Stem cells translational medicine.
[12] G. H. Coombs,et al. Metabolomic profiling and stable isotope labelling of Trichomonas vaginalis and Tritrichomonas foetus reveal major differences in amino acid metabolism including the production of 2-hydroxyisocaproic acid, cystathionine and S-methylcysteine , 2017, PloS one.
[13] Clare L. Bennett,et al. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation , 2017, Science Translational Medicine.
[14] Athanasios Mantalaris,et al. Metabolomics Analysis of the Osteogenic Differentiation of Umbilical Cord Blood Mesenchymal Stem Cells Reveals Differential Sensitivity to Osteogenic Agents , 2017, Stem cells and development.
[15] Y. Mu,et al. Mesenchymal stem cell therapy in type 2 diabetes mellitus , 2017, Diabetology & Metabolic Syndrome.
[16] N. Gadegaard,et al. Nanotopography controls cell cycle changes involved with skeletal stem cell self-renewal and multipotency , 2017, Biomaterials.
[17] Ben Wang,et al. Mitochondrial aerobic respiration is activated during hair follicle stem cell differentiation, and its dysfunction retards hair regeneration , 2016, PeerJ.
[18] Ping Jin,et al. Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming , 2016, Oncotarget.
[19] O. MacDougald,et al. Reciprocal Control of Osteogenic and Adipogenic Differentiation by ERK/MAP Kinase Phosphorylation of Runx2 and PPARγ Transcription Factors , 2016, Journal of cellular physiology.
[20] J. Locasale,et al. Correction to: 'The Warburg Effect: How Does it Benefit Cancer Cells?': [Trends in Biochemical Sciences, 41 (2016) 211]. , 2016, Trends in biochemical sciences.
[21] J. Locasale,et al. The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.
[22] Ivan Martin,et al. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. , 2016, Cytotherapy.
[23] E. Andreeva,et al. Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro , 2016, Cytotechnology.
[24] Junmin Lee,et al. Geometric guidance of integrin mediated traction stress during stem cell differentiation. , 2015, Biomaterials.
[25] Rein V. Ulijn,et al. Selection of Lineage Guiding Metabolites in Stem Cell Cultures , 2015 .
[26] Junmin Lee,et al. Influence of Biophysical Parameters on Maintaining the Mesenchymal Stem Cell Phenotype. , 2015, ACS biomaterials science & engineering.
[27] M. Maleki,et al. Comparison of Mesenchymal Stem Cell Markers in Multiple Human Adult Stem Cells , 2014, International journal of stem cells.
[28] Enateri V. Alakpa,et al. Nanotopographical induction of osteogenesis through adhesion, bone morphogenic protein cosignaling, and regulation of microRNAs. , 2014, ACS nano.
[29] Nikolaj Gadegaard,et al. Harnessing nanotopography and integrin-matrix interactions to influence stem cell fate. , 2014, Nature materials.
[30] Robert Langer,et al. Materials for stem cell factories of the future. , 2014, Nature materials.
[31] Keisuke Ito,et al. Metabolic requirements for the maintenance of self-renewing stem cells , 2014, Nature Reviews Molecular Cell Biology.
[32] M. Kassem,et al. Concise Review: Bridging the Gap: Bone Regeneration Using Skeletal Stem Cell‐Based Strategies—Where Are We Now? , 2014, Stem cells.
[33] Yufang Shi,et al. Immunobiology of mesenchymal stem cells , 2013, Cell Death and Differentiation.
[34] A. Friedenstein. Marrow Stromal Fibroblasts , 2014, Calcified Tissue International.
[35] B. Reid,et al. Enhanced tissue production through redox control in stem cell-laden hydrogels. , 2013, Tissue engineering. Part A.
[36] J. Triffitt,et al. Faculty Opinions recommendation of The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. , 2013 .
[37] Douglas Zhang,et al. The effect of mesenchymal stem cell shape on the maintenance of multipotency. , 2013, Biomaterials.
[38] David R McIlwain,et al. Caspase functions in cell death and disease. , 2013, Cold Spring Harbor perspectives in biology.
[39] D. Munn,et al. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. , 2013, Trends in immunology.
[40] Rainer Breitling,et al. mzMatch–ISO: an R tool for the annotation and relative quantification of isotope-labelled mass spectrometry data , 2012, Bioinform..
[41] Xu Cao,et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine , 2013, Nature Medicine.
[42] H. Northoff,et al. Lactate Influences the Gene Expression Profile of Human Mesenchymal Stem Cells (hMSC) in a Dose Dependant Manner , 2012, Cellular Physiology and Biochemistry.
[43] Kerstin Pingel,et al. 50 Years of Image Analysis , 2012 .
[44] Zhaohui Zheng,et al. Long-term culture in vitro impairs the immunosuppressive activity of mesenchymal stem cells on T cells. , 2012, Molecular medicine reports.
[45] Nikolaj Gadegaard,et al. Using nanotopography and metabolomics to identify biochemical effectors of multipotency. , 2012, ACS nano.
[46] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[47] Joost D de Bruijn,et al. The metabolism of human mesenchymal stem cells during proliferation and differentiation , 2011, Journal of cellular physiology.
[48] N. Gadegaard,et al. Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. , 2011, Nature materials.
[49] G. Schatten,et al. Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts , 2011, PloS one.
[50] Max E Valentinuzzi,et al. SAFETY AND EFFICACY , 2010 .
[51] Duncan Graham,et al. Introducing dip pen nanolithography as a tool for controlling stem cell behaviour: unlocking the potential of the next generation of smart materials in regenerative medicine. , 2010, Lab on a chip.
[52] Milan Mrksich,et al. Geometric cues for directing the differentiation of mesenchymal stem cells , 2010, Proceedings of the National Academy of Sciences.
[53] Matthias P Lutolf,et al. Artificial Stem Cell Niches , 2009, Advanced materials.
[54] A. Ben-Yehudah,et al. Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain. , 2009, Stem cell research.
[55] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[56] K. Anseth,et al. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. , 2008, Nature materials.
[57] G. Dini,et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.
[58] O. Lee,et al. Coordinated Changes of Mitochondrial Biogenesis and Antioxidant Enzymes During Osteogenic Differentiation of Human Mesenchymal Stem Cells , 2008, Stem cells.
[59] C. Wilkinson,et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. , 2007, Nature materials.
[60] Nigel W. Hardy,et al. Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.
[61] Renny T. Franceschi,et al. Critical role of the extracellular signal–regulated kinase–MAPK pathway in osteoblast differentiation and skeletal development , 2007, The Journal of cell biology.
[62] Andre Terzic,et al. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells , 2007, Nature Clinical Practice Cardiovascular Medicine.
[63] S. Sen,et al. Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.
[64] P. Stehle,et al. What are the essential elements needed for the determination of amino acid requirements in humans? , 2004, The Journal of nutrition.
[65] Christopher S. Chen,et al. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. , 2004, Developmental cell.
[66] C. Carlo-Stella,et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.
[67] P. Reeds,et al. Dispensable and indispensable amino acids for humans. , 2000, The Journal of nutrition.
[68] H. Niitani,et al. [Phase II study]. , 1995, Gan to kagaku ryoho. Cancer & chemotherapy.
[69] G S Stein,et al. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. , 1993, Endocrine reviews.
[70] A. Friedenstein. Precursor cells of mechanocytes. , 1976, International review of cytology.
[71] D. K. Owens,et al. Estimation of the surface free energy of polymers , 1969 .
[72] Otto Warburn,et al. THE METABOLISM OF TUMORS , 1931 .
[73] O. Warburg,et al. THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.